Simplified Chinese
First Public Disclosure of the Environmental Impact Assessment for the “Production Workshop Construction Project of Minhai Biotechnology’s Quadrivalent Inactivated Enterovirus Vaccine (Vero Cell)”
Release date:
2025-06-10
Author:
Source:
Abstract
According to the Measures for Public Participation in Environmental Impact Assessment (Ministry of Ecology and Environment No. 4 Order) requires that the “Minhai Biological Quadrivalent Inactivated Enterovirus Vaccine (“ True The environmental impact assessment information for the “Cell Production Workshop Construction Project” is hereby made public as follows:
I. Project Overview
Project Name: Minhai Biologics Quadrivalent Inactivated Enterovirus Vaccine ( True Cell Production Workshop Construction Project
Nature of the project: Expansion
Construction Site: Simiao Road, Biomedical Industry Base, Daxing District, Beijing 35 No. Beijing Minhai Biotechnology Co., Ltd. North Factory Area 2 Production Plant No. 2B district
Construction Entity: Beijing Minhai Biotechnology Co., Ltd.
Construction scope: This project utilizes the facilities of Beijing Minhai Biotechnology Co., Ltd., located on Simiao Road in the Daxing Biomedical Industry Base. 35 Within the North Factory Area 2 Production Plant No. 2B The district, by renovating and upgrading its factory facilities and introducing advanced production equipment, has established a quadrivalent inactivated enterovirus vaccine ( True Cell (original solution) production workshop, Upon completion, the project will have an annual production capacity of 437 liters of inactivated quadrivalent enterovirus vaccine (Vero cell) bulk. 。
II. Environmental Impact Assessment Agency
This time, Beijing Zhonghuan Shangda Environmental Protection Technology Co., Ltd. has been entrusted with conducting the environmental impact assessment for this project, preparing the relevant EIA documentation, and submitting it to the competent environmental protection administrative authority for approval.
III. Main Issues for Public Consultation
To solicit opinions and suggestions from all sectors of society regarding the project’s environmental protection efforts, this project is hereby made public to gather valuable feedback. Key issues for consideration include: your level of approval of the project’s construction from an environmental perspective; the potential impacts of the project on the surrounding environment and on your work and daily life; and your comments and recommendations on the project’s environmental protection measures.
IV. Main Methods for the Public to Submit Comments
During the public notice period, if the public has any comments or views regarding the project’s construction and the environmental impact assessment, please complete the Public Opinion Form and submit it to the project proponent. Link to download the Public Opinion Form: http://www.mee.gov.cn/xxgk2018/xxgk/xxgk01/201810/t20181024_665329.html Attachment 1
V. Contact Information
Construction Unit: Beijing Minhai Biotechnology Co., Ltd.
Contact: Zhang Yidi
Contact phone number: 15501168808
Email: zhangyidi@biominhai.com
Contact Address: Simiao Road, Biomedical Industry Base, Daxing District, Beijing 35 Number
Beijing Minhai Biotechnology Co., Ltd.
2025 year 6 month 10 day
Keywords:
Recommended Reading
Batch Release Status of the Company’s Products in 2026
2026-07-23
2026-07-15
2026-07-09